Literature DB >> 29986198

Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients.

Mingqiang Li1, Lu Ren1, Yingna Zhang2, Jie Lv2, Hua Fang2, Jing Zhang2, Xue Zhao2, Jiaojiao Han2, Pengwei Huang3, Ying Du4, Qingyong Zhang3, Junhong Yang5, Yunke Zhang5, Feng Gao6.   

Abstract

OBJECTIVES: To explore the characteristics of double seropositive myasthenia gravis (DSP-MG). PATIENTS AND METHODS: A literature review of twenty-four cases of DSP-MG including 2 novel cases presented in the current study, was performed.
RESULTS: Among 24 reported patients, 7 were male (29.17%) and 17 were female (70.83%). Among 20 patients with known age, the mean age of onset was 37.30 ± 19.50 years, among which the average onset age of the 6 male patients was 53.17 ± 8.98 years, while the average onset age of the remaining 14 female patients was 30.50 ± 18.94 years. Three patients had simple ocular muscle-type MG (14.28%), while 18 (85.71%) had non-ocular muscle-type MG. After administration of penicillide, 1 patient developed DSP-MG. In 9 cases, patients developed DSP-MG after thymectomy, while 5 patients naturally developed DSP-MG.
CONCLUSION: Women more frequently developed DSP-MG than men and men were diagnosed at an older age. MG is typically found in the ocular muscles, bulbar and limb muscles.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholine receptor antibody; Double-seropositive myasthenia gravis (DSP-MG); Muscle-specific tyrosine kinase antibody; Myasthenia gravis (MG)

Mesh:

Substances:

Year:  2018        PMID: 29986198     DOI: 10.1016/j.clineuro.2018.06.041

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

1.  Observation on the efficacy of different methylprednisolone regimens in the treatment of myasthenia gravis.

Authors:  Xiaoting Lin; Guoyan Qi
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

2.  Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes.

Authors:  Qi Huang; Feng Li; Song Zhao
Journal:  BMC Neurol       Date:  2022-03-04       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.